| Fiscal period | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|
| Period End Date | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | 12/31/2011 |
|---|
| Rental income | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Rental income : Triple-net leased | 695.27 | 780.90 | 737.80 | 840.13 | 845.83 | 779.80 | 674.55 | 586.02 | 819.88 | 627.72 |
| Rental income : Medical office buildings | 799.63 | 828.98 | 776.01 | 753.47 | 630.34 | 566.25 | 463.91 | 450.34 | 360.85 | 166.08 |
| Resident fees and services | 2,197.16 | 2,151.53 | 2,069.48 | 1,843.23 | 1,847.31 | 1,811.26 | 1,552.95 | 1,406.01 | 1,227.12 | 865.80 |
| Interest income from loans receivable | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Interest and other income | 7.61 | 10.98 | 24.89 | 6.03 | 0.88 | 1.05 | 4.26 | 2.02 | 1.11 | 1.22 |
| Gain on sale of Kindred Healthcare, Inc. common stock | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Medical office building services revenue | 15.19 | 11.16 | 13.42 | 13.68 | 21.07 | 41.49 | 29.36 | 17.81 | 20.74 | 36.47 |
| Income from loans and investments | 80.51 | 89.20 | 124.22 | 117.61 | 98.09 | 86.55 | 51.78 | 54.43 | 39.91 | 34.42 |
| Total Revenues | 3,795.36 | 3,872.75 | 3,745.81 | 3,574.15 | 3,443.52 | 3,286.40 | 2,776.81 | 2,516.62 | 2,469.62 | 1,731.70 |
| Rent reset costs | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Property-level operating expenses | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Medical office buildings | 256.61 | 260.25 | 243.68 | 233.01 | 191.78 | 174.23 | 158.83 | 153.24 | 125.40 | 56.99 |
| Medical office building services costs | 2.32 | 2.32 | 1.42 | 3.39 | 7.31 | 26.57 | 17.09 | 8.32 | 9.88 | 27.08 |
| Property-level operating expenses: Triple-net leased | 22.16 | 26.56 | -- | -- | -- | -- | -- | -- | -- | -- |
| Depreciation and amortization | 1,109.76 | 1,045.62 | 919.64 | 887.95 | 898.92 | 894.06 | 725.22 | 629.91 | 714.97 | 444.19 |
| Amortization of restricted stock grants | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock-based compensation | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| General, administrative and professional fees (including non-cash stock-based compensation expense of $1,820 and $727 fo | 130.16 | 158.73 | 145.98 | 135.49 | 126.88 | 128.04 | 121.74 | 115.08 | 98.51 | 74.54 |
| Professional fees | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Non-recurring employee severance costs | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Senior living | (1,658.67) | (1,521.40) | (1,446.20) | (1,250.07) | (1,242.98) | (1,209.42) | (1,036.56) | (956.68) | (841.02) | (588.10) |
| Litigation proceeds, net | -- | -- | -- | -- | -- | -- | -- | -- | -- | 202.26 |
| Interest | 469.54 | 451.66 | 442.50 | 448.20 | 419.74 | 367.11 | 292.07 | 249.01 | 288.72 | 223.80 |
| Interest on United States settlement | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Loss on impairment of assets | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Merger-related expenses | (29.81) | (15.24) | (30.55) | (10.54) | (24.64) | (102.94) | (43.30) | (21.63) | (63.18) | (153.92) |
| Loss on extinguishment of debt | (10.79) | (41.90) | (58.25) | (0.75) | (2.78) | (14.41) | (5.56) | (1.20) | (37.64) | (27.60) |
| Gain on sale of Kindred Healthcare, Inc. common stock | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Other | (0.71) | 10.34 | (72.77) | (20.05) | (9.99) | (17.96) | (25.74) | (17.36) | (6.94) | (7.27) |
| Foreign currency gain | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Reversal of contingent liability | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net gain on swap breakage | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net proceeds from litigation settlement | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Contribution to charitable foundation | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| United States Settlement | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Loss on uncollectible amounts due from tenants | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Allowance on loans receivable and investments | (24.24) | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Income (loss) before provision (benefit) for income taxes, gain on disposal of real estate assets, discontinued operatio | 80.59 | 359.42 | 384.83 | 584.71 | 518.51 | 351.68 | 350.70 | 364.18 | 283.35 | 330.47 |
| Provision (Benefit) for income taxes | (96.53) | (56.31) | (39.95) | (59.80) | (31.34) | (39.28) | (8.73) | (11.83) | (6.28) | (30.66) |
| Current | -- | -- | -- | (2.25) | (0.68) | 2.54 | 1.21 | -- | 1.21 | (4.08) |
| Deferred | -- | -- | -- | (57.55) | (30.66) | (41.83) | (9.94) | -- | (7.49) | (26.58) |
| Loss from unconsolidated entities | 1.84 | (2.45) | (55.03) | (0.56) | 4.36 | (1.42) | (0.14) | (0.51) | 18.15 | (0.05) |
| Net loss on real estate disposals | 262.22 | 26.02 | 46.25 | 717.27 | 98.20 | -- | -- | -- | -- | -- |
| Income from continuing operations | 441.19 | 439.30 | 415.99 | 1,361.22 | 652.41 | 389.54 | 359.30 | 375.50 | 307.79 | 361.08 |
| Discontinued operations | 0.00 | 0.00 | (0.01) | (0.11) | (0.92) | 11.10 | 99.74 | 79.17 | 53.99 | 2.19 |
| Income (loss) before extraordinary loss | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Extroardinary Income (Loss) | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Gain on real estate dispositions | -- | -- | -- | -- | -- | 18.58 | 17.97 | -- | -- | -- |
| Net income (loss) | 441.19 | 439.30 | 415.98 | 1,361.11 | 651.49 | 419.22 | 477.00 | 454.67 | 361.78 | 363.26 |
| Noncontrolling interest, net of tax | 2.04 | 6.28 | 6.51 | 4.64 | 2.26 | 1.38 | 1.23 | 1.16 | (1.03) | (1.23) |
| Preferred stock dividends and issuance costs | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net income(Loss) available to common stockholders | 439.15 | 433.02 | 409.47 | 1,356.47 | 649.23 | 417.84 | 475.77 | 453.51 | 362.80 | 364.49 |
| Income from continuing operations applicable to common shares | 1.18 | 1.20 | 1.17 | 3.83 | 1.89 | 1.18 | 1.28 | 1.28 | 1.06 | 1.59 |
| EPS (Basic) : Income from discontinued operations | -- | -- | -- | -- | -- | -- | 0.34 | 0.27 | 0.18 | 0.01 |
| Extraordinary loss on extinguishment of debt | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Earnings Per Share (Basic) | 1.18 | 1.18 | 1.15 | 3.82 | 1.88 | 1.26 | 1.62 | 1.55 | 1.24 | 1.60 |
| Income from continuing operations applicable to common shares | 1.17 | 1.19 | 1.16 | 3.80 | 1.87 | 1.17 | 1.26 | 1.27 | 1.05 | 1.57 |
| EPS (Diluted) : Income from discontinued operations | -- | -- | -- | -- | -- | -- | 0.34 | 0.27 | 0.18 | 0.01 |
| Extraordinary loss on extinguishment of debt | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Earnings Per Share (Diluted) | 1.17 | 1.17 | 1.14 | 3.78 | 1.86 | 1.25 | 1.60 | 1.54 | 1.23 | 1.58 |
| Weighted Average Shares Outstanding (Basic) | 373.37 | 365.98 | 356.27 | 355.33 | 344.70 | 330.31 | 294.18 | 292.65 | 292.06 | 228.45 |
| Weighted Average Shares Outstanding (Diluted) | 376.50 | 369.89 | 359.30 | 358.57 | 348.39 | 334.01 | 296.68 | 295.11 | 294.49 | 230.79 |
| Funds from operations (FFO) | 1,269.26 | 1,436.05 | 1,308.15 | 1,512.89 | 1,440.54 | 1,365.41 | 1,273.68 | 1,208.46 | 1,024.57 | 824.85 |